首页 | 本学科首页   官方微博 | 高级检索  
检索        

淋巴结转移率对甲状腺乳头状癌术后131I治疗临床转归的预测价值
引用本文:刘云,程腾,徐涛,夏文飞.淋巴结转移率对甲状腺乳头状癌术后131I治疗临床转归的预测价值[J].中国临床研究,2021(1):52-55.
作者姓名:刘云  程腾  徐涛  夏文飞
作者单位:华中科技大学同济医学院附属同济医院耳鼻喉科;华中科技大学同济医学院附属同济医院甲乳外科
基金项目:湖北省自然科学基金项目(2017CFC042)。
摘    要:目的 分析淋巴结转移率对甲状腺乳头状癌(PTC)患者手术后碘131(131I)清除残留甲状腺组织(清甲)治疗临床转归的预测价值.方法 采用回顾性研究方法,收集2015 年1 月至2017 年6 月收治的95 例PTC 患者的临床资料,手术后均行131I清甲治疗.依据患者淋巴结转移率的不同,分为A组(转移率≤10%)14...

关 键 词:甲状腺乳头状癌  碘131治疗  淋巴结转移率  临床转归  影响因素

Predictive value of lymph node metastasis rate for clinical outcome of postoperative 131I treatment in patients with thyroid papillary carcinoma
LIU Yun,CHENG Teng,XU Tao,XIA Wen-fei.Predictive value of lymph node metastasis rate for clinical outcome of postoperative 131I treatment in patients with thyroid papillary carcinoma[J].Chinese Journal of Clinical Research,2021(1):52-55.
Authors:LIU Yun  CHENG Teng  XU Tao  XIA Wen-fei
Institution:(Department of Otolaryngology,Tongji Hospital of Tongji Medical College,Huazhong University of Science and Technology,Wuhan,Hubei 430030,China;不详)
Abstract:Objective To analyze the predictive value of lymph node metastasis rate for the clinical outcome of patients with thyroid papillary carcinoma(PTC)treated after 131 I ablation of residual thyroid tissue treatment.Methods The clinical data of 95 PTC patients treated with 131 I ablation of residual tissue after operation from January 2015 to June 2017 were collected to analyze retrospectively.According to the different lymph node metastasis rate,the patients were divided into group A(metastasis rate≤10%,n=14),group B(metastasis rate>10%and≤25%,n=36),group C(metastasis rate>25%and≤50%,n=33),group D(metastasis rate>50%,n=12).During a median follow-up of 20 months(range 9 to 27 months),the clinical outcome of the patients after treatment(satisfaction,uncertainty,poor response)was observed and compared among these groups.ROC curve was drawed and used to evaluate the best diagnostic threshold and diagnostic efficacy of lymph node metastasis rate for predicting the clinical outcome,and multivariate logistic regression analysis was used to analyze the independent influencing factor for predicting the clinical outcome of PTC patients.Results There were no significant differences in gender,tumor stage,tumor site and tumor diameter(all P>0.05),but there were significant differences in ages,number of tumor lesions and extraglandular invasion(all P<0.01)and in the clinical outcomes among four groups(P<0.01).As the optimal diagnostic threshold of lymph node metastasis rate was 52.30%,the sensitivity,specificity and area under ROC curve were 53.57%,94.87%and 0.76,respectively.The ages,multiple foci,extraglandular invasion and lymph node metastasis rate were the independent factors influencing the clinical outcome(P<0.05,P<0.01).Conclusions The lymph node metastasis rate is closely related to the clinical outcome of PTC patients with 131 I ablation of residual thyroid tissue after surgery.The increase of lymph node metastasis rate is often associated with poor clinical outcome.The optimal diagnostic threshold of lymph node metastasis rate is 52.30%,which can be used as an independent and specific index to predict the clinical outcome of PTC patients.
Keywords:Papillary thyroid carcinoma  Iodine-131 therapy  Lymph node metastasis rate  Clinical outcome  Influencing factor
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号